Global Travel Vaccines Market 2015-2019

トラベルワクチン(海外渡航者ワクチン)の世界市場

◆タイトル:Global Travel Vaccines Market 2015-2019
◆商品コード:IRTNTR5448
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年3月11日
◆ページ数:84
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、トラベルワクチン(海外渡航者ワクチン)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、トラベルワクチン(海外渡航者ワクチン)の世界市場規模及び予測、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Travel Vaccines
Vaccines are biological preparations that provide immunity to a particular disease by stimulating the immune system. The vaccines can be administered orally, intra-nasally, or through injections in both adults and children. Government bodies such as the CDC and the NHS have mandated the vaccination of emigrants traveling to disease-prone areas to prevent the spread of infectious agents through them.

TechNavio’s analysts forecast the Global Travel Vaccines market to grow at a CAGR of 7.78 percent over the period 2014-2019.

[Covered in this Report]
Based on composition, the Global Travel Vaccines market is divided into two segments: Mono Vaccines and Combination Vaccines. This report covers the present scenario and the growth prospects of the Global Travel Vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sale of various vaccines administered to actively immunize against meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Travel Vaccines market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio’s report, Global Travel Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Travel Vaccines market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• GlaxoSmithKline
• Merck & Co.
• Novartis
• Sanofi

[Other Prominent Vendors]
• Beijing Minhai Biotechnology
• Bharat Biotech
• Bio Med
• Crucell
• CSL
• Dynavax Technologies
• Emergent Biosolutions
• Green Signal Bio Pharma
• Hualan Biological Engineering
• Imunoloski Zavod
• Indian Immunologicals
• Janssen Pharmaceuticals
• JN International Medical
• Kaketsuken
• LG Life Sciences
• Novavax
• Nuron Biotech
• Panacea Biotec
• Pfizer
• S K Chemicals
• Serum Institute of India
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• Vacunas Finlay
• Valneva

[Market Driver]
• Growing Demand among Travelers
• For a full, detailed list, view our report

[Market Challenge]
• Cold Chain Management
• For a full, detailed list, view our report

[Market Trend]
• Increased Awareness.
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Vaccine Approval Process

07.Late-stage Pipeline Candidates

08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Global Hepatitis A Vaccines Market
08.3.1 Market Size and Forecast
08.4 Five Forces Analysis

09.Market Segmentation by Composition
09.1 Mono Vaccine
09.1.1 Polysaccharide Vaccines
09.1.2 Conjugate Vaccines
09.2 Combination Vaccines

10.Geographical Segmentation

11.Buying Criteria

12.Market Growth Drivers

13.Drivers and their Impact

14.Market Challenges

15.Impact of Drivers and Challenges

16.Market Trends

17.Trends and their Impact

18.Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 SWOT Analysis: Global Travel Vaccines Market
18.2.2 GlaxoSmithKline
18.2.3 Merck
18.2.4 Novartis
18.2.5 Sanofi
18.3 Other and Future Prominent Vendors

19.Key Vendor Analysis
19.1 GlaxoSmithKline
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Sales by Geography
19.1.6 Pipeline Products
19.1.7 Business Strategy
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Merck
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation by Revenue 2013
19.2.4 Business Segmentation by Revenue 2012 and 2013
19.2.5 Sales by Geography
19.2.6 Business Strategy
19.2.7 Key Developments
19.2.8 SWOT Analysis
19.3 Novartis
19.3.1 Key Facts
19.3.2 Business Description
19.3.3 Business Segmentation
19.3.4 Revenue by Business Segmentation
19.3.5 Revenue Comparison 2012 and 2013
19.3.6 Sales by Geography
19.3.7 Business Strategy
19.3.8 Key Developments
19.3.9 SWOT Analysis
19.4 Sanofi
19.4.1 Key Facts
19.4.2 Business Description
19.4.3 Business Segmentation
19.4.4 Revenue by Business Segmentation
19.4.5 Revenue Comparison 2012 and 2013
19.4.6 Sales by Geography
19.4.7 Business Strategy
19.4.8 Key Developments
19.4.9 SWOT Analysis

20.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Vaccine Approval Process
Exhibit 3: Global Travel Vaccines Market 2014-2019 (US$ million)
Exhibit 4: Global Hepatitis A Vaccines Market 2014-2019 (US$ million)
Exhibit 5: Market Share of the Different Type of Travel Vaccines, 2014 (in percentage)
Exhibit 6: Global Travel Vaccines Market Segmentation by Composition
Exhibit 7: Segmentation of Global Travel Vaccines Market by Geography 2014
Exhibit 8: SWOT Analysis: Global Travel Vaccines Market 2015-2019
Exhibit 9: GlaxoSmithKline: Revenue 2013
Exhibit 10: GlaxoSmithKline: Vaccine Pipeline
Exhibit 11: Merck: Revenue 2013
Exhibit 12: Novartis: Revenue 2013
Exhibit 13: Novartis: Vaccine Pipeline
Exhibit 14: Sanofi: Revenue 2013
Exhibit 15: GlaxoSmithKline: Business Segmentation 2013
Exhibit 16: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 17: GlaxoSmithKline: Sales by Geography 2013
Exhibit 18: GlaxoSmithKline: Pipeline Products 2013
Exhibit 19: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 20: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 21: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 22: Novartis AG: Business Segmentation
Exhibit 23: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 24: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 25: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 26: Sanofi SA: Business Segmentation
Exhibit 27: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 28: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 29: Sanofi SA: Sales Revenue by Geographical Segmentation 2013



【掲載企業】

GlaxoSmithKline, Merck & Co., Novartis, Sanofi, Beijing Minhai Biotechnology, Bharat Biotech, Bio Med, Crucell, CSL, Dynavax Technologies, Emergent Biosolutions, GreenSignal Bio Pharma, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG LifeSciences, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, S K Chemicals, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, Vacunas Finlay, Valneva

【資料のキーワード】

トラベルワクチン、海外渡航者ワクチン、多糖類ワクチン、結合型ワクチン、混合ワクチン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[トラベルワクチン(海外渡航者ワクチン)の世界市場] (Global Travel Vaccines Market 2015-2019 / IRTNTR5448)販売に関する免責事項
[トラベルワクチン(海外渡航者ワクチン)の世界市場] (Global Travel Vaccines Market 2015-2019 / IRTNTR5448)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆